Literature DB >> 23614626

Insights into BAY 60-2770 activation and S-nitrosylation-dependent desensitization of soluble guanylyl cyclase via crystal structures of homologous nostoc H-NOX domain complexes.

Vijay Kumar1, Faye Martin, Michael G Hahn, Martina Schaefer, Jonathan S Stamler, Johannes-Peter Stasch, Focco van den Akker.   

Abstract

The soluble guanylyl cyclase (sGC) is an important receptor for nitric oxide (NO). Nitric oxide activates sGC several hundred fold to generate cGMP from GTP. Because of sGC's salutary roles in cardiovascular physiology, it has received substantial attention as a drug target. The heme domain of sGC is key to its regulation as it not only contains the NO activation site but also harbors sites for NO-independent sGC activators as well an S-nitrosylation site (β1 C122) involved in desensitization. Here we report the crystal structure of the activator BAY 60-2770 bound to the Nostoc H-NOX domain that is homologous to sGC. The structure reveals that BAY 60-2770 has displaced the heme and acts as a heme mimetic via carboxylate-mediated interactions with the conserved YxSxR motif as well as hydrophobic interactions. Comparisons with the previously determined BAY 58-2667 bound structure reveal that BAY 60-2770 is more ordered in its hydrophobic tail region. sGC activity assays demonstrate that BAY 60-2770 has about 10% higher fold maximal stimulation compared to BAY 58-2667. S-Nitrosylation of the BAY 60-2770 substituted Nostoc H-NOX domain causes subtle changes in the vicinity of the S-nitrosylated C122 residue. These shifts could impact the adjacent YxSxR motif and αF helix and as such potentially inhibit either heme incorporation or NO-activation of sGC and thus provide a structural basis for desensitization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23614626      PMCID: PMC3775905          DOI: 10.1021/bi301657w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  50 in total

1.  Macromolecular TLS refinement in REFMAC at moderate resolutions.

Authors:  Martyn D Winn; Garib N Murshudov; Miroslav Z Papiz
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

2.  Structure validation by Calpha geometry: phi,psi and Cbeta deviation.

Authors:  Simon C Lovell; Ian W Davis; W Bryan Arendall; Paul I W de Bakker; J Michael Word; Michael G Prisant; Jane S Richardson; David C Richardson
Journal:  Proteins       Date:  2003-02-15

Review 3.  Physiology and pathophysiology of vascular signaling controlled by guanosine 3',5'-cyclic monophosphate-dependent protein kinase [corrected].

Authors:  Thomas Münzel; Robert Feil; Alexander Mülsch; Suzanne M Lohmann; Franz Hofmann; Ulrich Walter
Journal:  Circulation       Date:  2003-11-04       Impact factor: 29.690

4.  Rational protein crystallization by mutational surface engineering.

Authors:  Zygmunt S Derewenda
Journal:  Structure       Date:  2004-04       Impact factor: 5.006

Review 5.  Soluble guanylate cyclase: a potential therapeutic target for heart failure.

Authors:  Mihai Gheorghiade; Catherine N Marti; Hani N Sabbah; Lothar Roessig; Stephen J Greene; Michael Böhm; John C Burnett; Umberto Campia; John G F Cleland; Sean P Collins; Gregg C Fonarow; Phillip D Levy; Marco Metra; Bertram Pitt; Piotr Ponikowski; Naoki Sato; Adriaan A Voors; Johannes-Peter Stasch; Javed Butler
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

6.  S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function.

Authors:  Kenny K K Chung; Bobby Thomas; Xiaojie Li; Olga Pletnikova; Juan C Troncoso; Laura Marsh; Valina L Dawson; Ted M Dawson
Journal:  Science       Date:  2004-04-22       Impact factor: 47.728

Review 7.  S-nitrosylation in health and disease.

Authors:  Matthew W Foster; Timothy J McMahon; Jonathan S Stamler
Journal:  Trends Mol Med       Date:  2003-04       Impact factor: 11.951

8.  A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation.

Authors:  Emil Martin; Iraida Sharina; Alexander Kots; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

9.  NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle.

Authors:  Johannes-Peter Stasch; Peter Schmidt; Cristina Alonso-Alija; Heiner Apeler; Klaus Dembowsky; Michael Haerter; Markus Heil; Torsten Minuth; Elisabeth Perzborn; Ulrich Pleiss; Matthias Schramm; Werner Schroeder; Henning Schröder; Elke Stahl; Wolfram Steinke; Frank Wunder
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

10.  Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock.

Authors:  Limin Liu; Yun Yan; Ming Zeng; Jian Zhang; Martha A Hanes; Gregory Ahearn; Timothy J McMahon; Timm Dickfeld; Harvey E Marshall; Loretta G Que; Jonathan S Stamler
Journal:  Cell       Date:  2004-02-20       Impact factor: 41.582

View more
  21 in total

Review 1.  Thiol-Based Redox Modulation of Soluble Guanylyl Cyclase, the Nitric Oxide Receptor.

Authors:  Annie Beuve
Journal:  Antioxid Redox Signal       Date:  2016-04-01       Impact factor: 8.401

Review 2.  Bacterial Haemoprotein Sensors of NO: H-NOX and NosP.

Authors:  Bezalel Bacon; Lisa-Marie Nisbett; Elizabeth Boon
Journal:  Adv Microb Physiol       Date:  2017-03-18       Impact factor: 3.517

Review 3.  Stimulators and activators of soluble guanylate cyclase for urogenital disorders.

Authors:  Fabiola Z Mónica; Edson Antunes
Journal:  Nat Rev Urol       Date:  2017-11-14       Impact factor: 14.432

Review 4.  New insights into the role of soluble guanylate cyclase in blood pressure regulation.

Authors:  Emmanuel Buys; Patrick Sips
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-03       Impact factor: 2.894

5.  Regulation of sGC via hsp90, Cellular Heme, sGC Agonists, and NO: New Pathways and Clinical Perspectives.

Authors:  Arnab Ghosh; Dennis J Stuehr
Journal:  Antioxid Redox Signal       Date:  2016-05-02       Impact factor: 8.401

6.  Guanylyl cyclase sensitivity to nitric oxide is protected by a thiol oxidation-driven interaction with thioredoxin-1.

Authors:  Can Huang; Maryam Alapa; Ping Shu; Narayani Nagarajan; Changgong Wu; Junichi Sadoshima; Vladyslav Kholodovych; Hong Li; Annie Beuve
Journal:  J Biol Chem       Date:  2017-06-28       Impact factor: 5.157

7.  Insights into soluble guanylyl cyclase activation derived from improved heme-mimetics.

Authors:  Margarete von Wantoch Rekowski; Vijay Kumar; Focco van den Akker; Athanassios Giannis; Andreas Papapetropoulos; Zongmin Zhou; Johann Moschner; Antonia Marazioti; Marina Bantzi; Georgios A Spyroulias
Journal:  J Med Chem       Date:  2013-10-24       Impact factor: 7.446

8.  S-Nitrosation of Conserved Cysteines Modulates Activity and Stability of S-Nitrosoglutathione Reductase (GSNOR).

Authors:  Damian Guerra; Keith Ballard; Ian Truebridge; Elizabeth Vierling
Journal:  Biochemistry       Date:  2016-04-20       Impact factor: 3.162

Review 9.  Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress.

Authors:  Andreas Daiber; Thomas Münzel
Journal:  Antioxid Redox Signal       Date:  2015-09-24       Impact factor: 8.401

10.  Direct Measurement of S-Nitrosothiols with an Orbitrap Fusion Mass Spectrometer: S-Nitrosoglutathione Reductase as a Model Protein.

Authors:  Damian Guerra; Ian Truebridge; Stephen J Eyles; Patrick Treffon; Elizabeth Vierling
Journal:  Methods Mol Biol       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.